Galaxy Therapeutics INC
3 clinical trials · Sponsor
◉ Watch Galaxy Therapeutics INC
| Record | Firm | Date |
|---|---|---|
| SEAL™IT: Saccular Endovascular Aneurysm Lattice System Interventional Pivotal Trial (NCT05831202) | Galaxy Therapeutics INC | 2024-08-06 |
| SEAL™ME: Saccular Endovascular Aneurysm Lattice System Multicenter Enrollment Global Registry (NCT05880680) | Galaxy Therapeutics INC | 2023-10-09 |
| Pre-SEAL™IT: Saccular Endovascular Aneurysm Lattice System First In Human Interventional Trial (NCT05686733) | Galaxy Therapeutics INC | 2022-01-26 |
Track Galaxy Therapeutics INC automatically
Every clearance here is in the API, with alerts when new ones post.